Table 2: Demographic characteristics of the study groups.
|
Treatment Groups (number = 26 for each) |
|
|
A (saline N) |
B (H saline N) |
C (saline IV) |
D (H saline IV) |
P-value* |
|
Age in year (Mean ± SD) |
40.4 (6.2) |
41.3 (5.6) |
43.2 (6.1) |
39.5 (9.4) |
0.269 |
|
Body weight in kg (Mean ± SD) |
81.7 (6.5) |
82.2 (5.9) |
84.4 (5.8) |
83.5 (4.6) |
0.317 |
| Male/Female |
11/15 |
14/12 |
13/13 |
16/10 |
0.572 |
Group A (saline N): Standard pharmacotherapy +normal saline 0.9% (5ml) nebulizer /8hr.
Group B (H saline N): Standard pharmacotherapy + hypertonic saline 3% (5ml) nebulizer /8hr
Group C (saline IV):Standard pharmacotherapy + normal saline 0.9% (500ml) intravenous /24hr
Group D (A saline IV Standard pharmacotherapy + hypertonic saline 3% (500ml) intravenous /24hr
Abbreviations: SD: standard deviation.
* ANOVA with Least Significant Difference test was used for between-group comparisons of means and x2 test for comparison of proportions. Significance level was at P-value ≤0.05